Faculty of Medicine, Faculty of medicine, Jordan University of Science and Technology, Irbid, Jordan.
J Cardiothorac Surg. 2024 Sep 9;19(1):518. doi: 10.1186/s13019-024-03009-x.
Stroke is a potentially debilitating complication of heart valve replacement surgery, with rates ranging from 1 to 10%. Despite advancements in surgical techniques, the incidence of postoperative stroke remains a significant concern, impacting patient outcomes and healthcare resources. This study aims to investigate the incidence, risk factors, and outcomes of in-hospital adverse neurologic events, particularly stroke, following valve replacement. The analysis focuses on identifying patient characteristics and procedural factors associated with increased stroke risk.
This retrospective study involves a review of 417 consecutive patients who underwent SVR between January 2004 and December 2022. The study cohort was extracted from a prospectively recorded cardiac intensive care unit database. Preoperative and perioperative data were collected, and subjects with specific exclusion criteria were omitted from the analysis. The analysis includes demographic information, preoperative risk factors, and perioperative variables.
The study identified a 4.3% incidence of postoperative stroke among SVR patients. Risk factors associated with increased stroke susceptibility included prolonged cardiopulmonary bypass time, aortic cross-clamp duration exceeding 90 min, prior stroke history, diabetes mellitus, and mitral valve annulus calcification. Patients undergoing combined procedures, such as aortic valve replacement with mitral valve replacement or coronary artery bypass grafting with AVR and MVR, (OR = 10.74, CI:2.65-43.44, p-value = < 0.001) and (OR = 11.66, CI:1.02-132.70, p-value = 0.048) respectively, exhibited elevated risks. Internal carotid artery stenosis (< 75%) and requiring prolonged inotropic support were also associated with increased stroke risk(OR = 3.04, CI:1.13-8.12, P-value = 0.026). The occurrence of stroke correlated with extended intensive care unit stay (OR = 1.12, CI: 1.04-1.20, P-value = 0.002) and heightened in-hospital mortality.
In conclusion, our study identifies key risk factors and underscores the importance of proactive measures to reduce postoperative stroke incidence in surgical valve replacement patients.
中风是心脏瓣膜置换手术后潜在的致残并发症,发生率为 1%至 10%。尽管手术技术有所进步,但术后中风的发生率仍然是一个重大问题,影响患者的预后和医疗资源。本研究旨在调查瓣膜置换术后住院期间不良神经事件(尤其是中风)的发生率、风险因素和结果。该分析重点是确定与增加中风风险相关的患者特征和手术因素。
这是一项回顾性研究,涉及 2004 年 1 月至 2022 年 12 月期间连续进行的 417 例 SVR 患者。该研究队列是从一个前瞻性记录的心脏重症监护病房数据库中提取的。收集了术前和围手术期数据,并排除了具有特定排除标准的受试者。该分析包括人口统计学信息、术前危险因素和围手术期变量。
研究发现 SVR 患者术后中风的发生率为 4.3%。与增加中风易感性相关的风险因素包括体外循环时间延长、主动脉阻断时间超过 90 分钟、既往中风史、糖尿病和二尖瓣瓣环钙化。接受联合手术的患者(如主动脉瓣置换加二尖瓣置换或冠状动脉旁路移植术加主动脉瓣置换和二尖瓣置换)(比值比 = 10.74,95%置信区间:2.65-43.44,P 值 < 0.001)和(比值比 = 11.66,95%置信区间:1.02-132.70,P 值 = 0.048),风险增加。颈内动脉狭窄(<75%)和需要长时间使用正性肌力药物也与增加中风风险相关(比值比 = 3.04,95%置信区间:1.13-8.12,P 值 = 0.026)。中风的发生与延长的重症监护病房住院时间相关(比值比 = 1.12,95%置信区间:1.04-1.20,P 值 = 0.002)和住院死亡率升高相关。
总之,我们的研究确定了关键的风险因素,并强调了采取积极措施降低心脏瓣膜置换术后患者术后中风发生率的重要性。